New Report Just Published: World Multiple Myeloma Therapeutics Market Report
... Takeda Acquires Millennium Pharmaceuticals II-48 GlaxoSmithKline Forms Alliance with OncoMed for Developing Cancer Therapeutics II-48 cyclacel Signs Agreement to Acquire ALIGN Pharmaceuticals II-49 Biogen and Genentech to Jointly Develop and Commercialize New Blood Cancer Drug II-49 ...Cyclacel Pharmaceuticals to Present Preclinical Data on Sapacitabine and Seliciclib at AACR
... NSCLC About cyclacel Pharmaceuticals, Inc. cyclacel is a biopharmaceutical company dedicated to the di...of activity in terms of Progression Free Survival. cyclacel also intends to initiate a Phase II trial of selic...Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
...opment and Regulatory Affairs of Cyclacel. About cyclacel Pharmaceuticals, Inc. cyclacel is a biopharmaceutical company dedicated to the di...eat human cancers and other serious disorders. Two cyclacel drugs are in Phase II trials: sapacitabine (CYC682...